J7354 HCPCS Level II code: Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
J7354 is the HCPCS code for “Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7354Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
Short description: Cantharidin top, applicator
HCPCS · United States
Medicare details
The indicators CMS publishes with J7354 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Apr 1, 2024
Where J7354 sits
- 1J codesDrugs administered other than orally
- 2Active code J7354Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7354 mean?
J7354 is the HCPCS code for “Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7354?
CMS lists J7354’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7354
All J codesJ7340Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 mlJ7342Instillation, ciprofloxacin otic suspension, 6 mgJ7345Aminolevulinic acid hcl for topical administration, 10% gel, 10 mgJ7351Injection, bimatoprost, intracameral implant, 1 microgramJ7352Afamelanotide implant, 1 mgJ7353Anacaulase-bcdb, 8.8% gel, 1 gramJ7355Injection, travoprost, intracameral implant, 1 microgramJ7356Injection, foscarbidopa 0.25 mg/foslevodopa 5 mgJ7401Mometasone furoate sinus implant, 10 microgramsJ7402Mometasone furoate sinus implant, (sinuva), 10 microgramsJ7500Azathioprine, oral, 50 mgJ7501Azathioprine, parenteral, 100 mg